Document Detail

Antiretroviral Preexposure Prophylaxis for HIV Prevention.
MedLine Citation:
PMID:  23281985     Owner:  NLM     Status:  In-Data-Review    
To the Editor: Thigpen et al. (Aug. 2 issue)(1) report that persons who are seronegative for the human immunodeficiency virus (HIV) and who are receiving tenofovir disoproxil fumarate and emtricitabine (TDF-FTC) for preexposure prophylaxis had decreased bone mineral density at 24 months, as compared with those receiving placebo. In HIV-infected cohorts, TDF causes an initial loss of bone density over a period of 6 to 12 months, but there is stable bone density subsequently.(2),(3) These findings are consistent with other studies that have shown short-term loss of bone density in patients initiating antiretroviral treatment but stable bone density in . . .
Related Documents :
310885 - Circulating immune complexes in systemic lupus erythematosus. association with other im...
21886325 - Hiv/aids knowledge scores and perceptions of risk among african american students atten...
12729055 - Mitral valve prolapse in systemic lupus erythematosus patients: clinical and immunologi...
21570555 - Low-dose combined oral contraceptive and cervicovaginal shedding of human immunodeficie...
7811545 - Wasting syndrome: nutritional support in hiv infection.
1663575 - Serial observations of chronic rotavirus infection in an immunodeficient child.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The New England journal of medicine     Volume:  368     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  82-4     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intraaortic balloon support for cardiogenic shock.
Next Document:  Antiretroviral Preexposure Prophylaxis for HIV Prevention.